Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasome. (2023)

First Author: Ossola B
Attributed to:  New insights into NLRP3 within inflammatory disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.neuropharm.2022.109330

PubMed Identifier: 36375694

Publication URI: http://europepmc.org/abstract/MED/36375694

Type: Journal Article/Review

Volume: 224

Parent Publication: Neuropharmacology

ISSN: 0028-3908